Ned Desmond on Muck Rack

Ned Desmond

As seen in: Yahoo Entertainment, Yahoo Life, Yahoo Canada, Yahoo News Philippines, Yahoo Singapore, Engadget, TechCrunch, Yahoo Finance, Yahoo Finance Australia, Yahoo and
Lots to learn. Always a reporter. SOSV | Sight Tech Global | ex-TechCrunch and so many things
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ned

Contact Ned, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Announcing the SOSV Deep Tech Summit, coming November 4-6

|
By Ned Desmond
| SOSV Deep Tech LIVE
At SOSV, we know there’s an eager audience for smart conversations with the best deep tech founders, technologists and investors. We programmed the SOSV Climate Tech Summit each fall for the past five years, and our 100-speaker agendas pulled in 10,000 participants each time.
Open in Who Shared Issue with article?

The Twisted Consequences of Chatbots

|
By Ned Desmond
| First Things
In December last year, the autonomous robotaxi firm Waymo took a notable victory lap. The occasion was an independent analysis of Waymo’s safety record based on data from nearly 100 million miles of Waymo operations. The analysis indicated that passengers in a Waymo suffered “91 percent fewer serious-injury-or-worse crashes” than passengers in a human-piloted car over the same roads.
Open in Who Shared Issue with article?

Announcing the 2024 Human Health 100

|
By Ned Desmond
| sosv.com
Welcome to the third annual SOSV Human Health 100. The list features SOSV’s 100 most exciting companies in the health category, which for SOSV ranges very widely, from assistive robotics and remote care to therapeutics and diagnostics. In the past two years (see the 2023 and 2022 lists), venture rounds and company valuations grew strongly, but in the past year funding has become much harder to secure and valuations are fragile at best.
Open in Who Shared Issue with article?
See all 221 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Ned

Contact Ned, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified